Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis

Overview of attention for article published in World Journal of Surgical Oncology, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 48 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Konsultationfassung: Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms: Langfassung der Leitlinie "Konsultationfassung: Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms"

Cited by The Association of the Scientific Medical Societies in Germany on 27 May 2022

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

Lung cancer: diagnosis and management : C: Clinical and cost effectiveness of treatment regimen for the treatment of operable Stage IIIA-N2 NSCLC

Cited by National Institute for Health and Care Excellence on 18 Apr 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.